Tramiprosate

Discontinued Product

Tramiprosate (Cat. No. 3619) has been withdrawn from sale for commercial reasons.
Cat.No. 3619 - Tramiprosate | C3H9NO3S | CAS No. 3687-18-1
Description: Targets soluble Aβ to decrease amyloid plaque deposition. Also GABA analog
Alternative Names: Homotaurine
Chemical Name: 3-Amino-1-propanesulfonic acid
Datasheet
Citations
Reviews
Literature (2)

Biological Activity for Tramiprosate

Tramiprosate is a sulfated glycosaminoglycan (sGAG) mimetic that targets soluble amyloid β (Aβ) and maintains Aβ in a non-fibrillar form. Decreases Aβ42-induced neuronal death and inhibits amyloid deposition in vitro. Decreases brain amyloid plaque load by 30%, increases tau polymerization and is brain penetrant. Also a GABA analog that protects against the convulsant and cytotoxic activity of kainic acid in vivo.

Technical Data for Tramiprosate

M. Wt 139.17
Formula C3H9NO3S
Storage Store at +4°C
CAS Number 3687-18-1
PubChem ID 1646
InChI Key SNKZJIOFVMKAOJ-UHFFFAOYSA-N
Smiles NCCCS(=O)(O)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for Tramiprosate

References are publications that support the biological activity of the product.

Fariello et al (1982) Homotaurine (3 aminopropanesulfonic acid; 3APS) protects from the convulsant and cytotoxic effect of systemically administered kainic acid. Neurology 32 241 PMID: 7199633

Gervais et al (2007) Targeting soluble Aβ peptide with tramiprosate for the treatment of brain amyloidosis. Neurobiol.Aging 28 537 PMID: 16675063

Santa-Maria et al (2007) Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau. Mol.Neurodegen. 2 17

View Related Products by Target

Keywords: Tramiprosate, Tramiprosate supplier, Sulfated, glycosaminoglycan, sGAG, Targets, soluble, Amyloid-beta, β-Amyloid, beta-Amyloid, b-amyloid, decrease, amyloid, plaque, deposition, Precursor, Protein, APP, Secretase, beta, Peptides, GABAA, GABAC, GABAB, Receptors, analogue, amyloidb, amyloidβ, Homotaurine, Amyloid, Beta, Miscellaneous, GABA, 3619, Tocris Bioscience

Citations for Tramiprosate

Citations are publications that use Tocris products.

Currently there are no citations for Tramiprosate.

Reviews for Tramiprosate

There are currently no reviews for this product. Be the first to review Tramiprosate and earn rewards!

Have you used Tramiprosate?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Neurodegeneration

Neurodegeneration Product Guide

A collection of over 275 products for neurodegeneration research, the guide includes research tools for the study of:

  • Alzheimer's disease
  • Parkinson's disease
  • Huntington's disease
Alzheimer's

Alzheimer's Poster

Alzheimer's disease (AD) is a degenerative brain disease and the most common cause of dementia, affecting approximately 47 million people worldwide. Updated in 2015, this poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease, as well as classic AD drug targets.